Cargando…
Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236388/ https://www.ncbi.nlm.nih.gov/pubmed/37268605 http://dx.doi.org/10.1038/s41392-023-01498-1 |
| _version_ | 1785052908071419904 |
|---|---|
| author | Ruan, Qiao-ling Wang, Zhi-chao Wei, Cheng-jiang Wang, Wei Yang, Qing-luan Wu, Jing Wan, Yan-min Ge, Ling-ling Zhang, Wen-hong Li, Qing-feng |
| author_facet | Ruan, Qiao-ling Wang, Zhi-chao Wei, Cheng-jiang Wang, Wei Yang, Qing-luan Wu, Jing Wan, Yan-min Ge, Ling-ling Zhang, Wen-hong Li, Qing-feng |
| author_sort | Ruan, Qiao-ling |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10236388 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102363882023-06-04 Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1 Ruan, Qiao-ling Wang, Zhi-chao Wei, Cheng-jiang Wang, Wei Yang, Qing-luan Wu, Jing Wan, Yan-min Ge, Ling-ling Zhang, Wen-hong Li, Qing-feng Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-06-02 /pmc/articles/PMC10236388/ /pubmed/37268605 http://dx.doi.org/10.1038/s41392-023-01498-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Ruan, Qiao-ling Wang, Zhi-chao Wei, Cheng-jiang Wang, Wei Yang, Qing-luan Wu, Jing Wan, Yan-min Ge, Ling-ling Zhang, Wen-hong Li, Qing-feng Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1 |
| title | Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1 |
| title_full | Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1 |
| title_fullStr | Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1 |
| title_full_unstemmed | Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1 |
| title_short | Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1 |
| title_sort | neutralizing antibodies against sars-cov-2 virus after vaccination in patients with neurofibromatosis type 1 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236388/ https://www.ncbi.nlm.nih.gov/pubmed/37268605 http://dx.doi.org/10.1038/s41392-023-01498-1 |
| work_keys_str_mv | AT ruanqiaoling neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT wangzhichao neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT weichengjiang neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT wangwei neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT yangqingluan neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT wujing neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT wanyanmin neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT gelingling neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT zhangwenhong neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 AT liqingfeng neutralizingantibodiesagainstsarscov2virusaftervaccinationinpatientswithneurofibromatosistype1 |